Full Text
Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population

Abstract

Authors

T. Dilla L. Lizán S. Paz P. Garrido C. Avendaño J.J. Cruz J. Espinosa J.A. Sacristan

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×